Proshares Ultra Nasd BiotechBIBETF
13F holders, Q1 2025 (March 31)23holders −1
5new positions
6sold out
1famous investor
$48.18avg. 13F price*
At the end of Q1 2025, 23 institutions reported holding Proshares Ultra Nasd Biotech (BIB) in their 13F filings, down 1 from Q4 2024. 5 opened new positions and 6 sold out. The largest holders were IMC-Chicago, LLC ($1.1M), Susquehanna International Group, LLP ($669K) and Citadel Advisors ($519K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Proshares Ultra Nasd Biotech
- CUSIP
- 74347R214
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.1M |
| Exits | 6 | $517K |
All 13F filers, Q4 2024 → Q1 2025: 30,341 shares bought and 17,870 shares sold, net +12,471 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| IMC-Chicago, LLC | 0.04% | New | 22,406 | $1.1M |
| Susquehanna International Group, LLP | 0.00% | Add +13.4% | 13,877 | $669K |
| Citadel Advisors | 0.00% | Add +86.1% | 10,766 | $519K |
| Chase Investment Counsel Corp. | 0.16% | No change | 8,980 | $432K |
| Westwood Wealth Management | 0.17% | No change | 8,000 | $385K |
| Capital Investment Advisors, LLC | 0.01% | Reduce -30.2% | 6,981 | $336K |
| Toth Financial Advisory Corp. | 0.03% | Reduce -35.0% | 5,626 | $271K |
| Tower Research Capital LLC (TRC) | 0.01% | Reduce -16.7% | 4,436 | $214K |
| PNC Financial Services Group, Inc. | 0.00% | New | 1,000 | $48K |
| Park Square Financial Group, LLC | 0.01% | No change | 316 | $15K |
| Laurel Wealth Advisors LLC | 0.00% | No change | 300 | $14K |
| MAI Capital Management | 0.00% | No change | 250 | $12K |
| Garde Capital, Inc. | 0.00% | New | 236 | $11K |
| Harel Insurance Investments & Financial Services Ltd. | 0.00% | No change | 198 | $10K |
| Hantz Financial Services, Inc. | 0.00% | No change | 178 | $9K |
| Truvestments Capital LLC | 0.00% | No change | 125 | $6K |
| Whittier Trust Co. | 0.00% | No change | 75 | $4K |
| Morgan Stanley | 0.00% | Reduce -66.5% | 66 | $3K |
| Qube Research & Technologies Ltd | 0.00% | No change | 53 | $3K |
| Royal Bank of Canada | 0.00% | New | 40 | $2K |
| Chilton Capital Management LLC | 0.00% | New | 39 | $2K |
| UBS Group AG | 0.00% | Reduce -99.8% | 1 | $48 |
| Wells Fargo & Company | 0.00% | Reduce -50.0% | 1 | $29 |
"% of holder's portfolio" is BIB's weight in each manager's 13F, not the share of Proshares Ultra Nasd Biotech the manager owns.